Quemliclustat

4 trials 1 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

2 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase III: 1 Phase II: 2 Phase I/II: 1

Sponsors using this IMP

Arcus Biosciences Inc. 3 Gilead Sciences Inc. 1

All trials

4 total

Randomized Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Ade… Recruiting

2024-513317-12-00 Phase III 9 countries Arcus Biosciences Inc.
Study with Various Immunotherapy Treatments in Participants With Lung Cancer Ended

2022-502916-35-01 Phase II 4 countries Gilead Sciences Inc.
A safety and efficacy study of treatment combinations with and without chemotherapy in adult patients with advanced upper gastrointestinal t… Ended

2024-511917-40-00 Phase II 1 country Arcus Biosciences Inc.
A Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer Ended

2024-511158-36-00 Phase I/II 3 countries Arcus Biosciences Inc.

Showing 1–4 of 4 trials

← All drugs A–Z